Array Biopharma, Inc. (ARRY) Tops Q4 EPS by 7c
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q4 EPS of ($0.06) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
